Stock Rating Upgrade
Of late the Value Trend Rating for Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) improved from C to B reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
On 9/5/25, Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) stock rose modestly by 0.9%, closing at $26.54. However, this advance was accompanied by exceptionally low trading volume at -3% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -17.5% during the last week.
Current PriceTarget Research Rating
Tonix Pharmaceuticals Holding has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Tonix Pharmaceuticals Holding has a poor Appreciation Score of 26 but a very high Power Rating of 95, leading to the Positive Value Trend Rating.
Be the first to comment